These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21512310)

  • 1. Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma.
    Liu W; Xu G; Ma J; Jia W; Li J; Chen K; Wang W; Hao C; Wang Y; Wang X
    Tohoku J Exp Med; 2011 May; 224(1):29-39. PubMed ID: 21512310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells.
    Wu XL; Lin KJ; Bai AP; Wang WX; Meng XK; Su XL; Hou MX; Dong PD; Zhang JJ; Wang ZY; Shi L
    World J Gastroenterol; 2014 Aug; 20(30):10440-8. PubMed ID: 25132760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.
    Liu WB; Xu GL; Jia WD; Li JS; Ma JL; Chen K; Wang ZH; Ge YS; Ren WH; Yu JH; Wang W; Wang XJ
    Med Oncol; 2011 Dec; 28 Suppl 1():S228-38. PubMed ID: 20957524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin promotes hepatocellular carcinoma invasion by up-regulating MMP-2 and uPA expression.
    Chen RX; Xia YH; Xue TC; Ye SL
    Mol Biol Rep; 2011 Aug; 38(6):3671-7. PubMed ID: 21104439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
    Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling.
    Jue C; Lin C; Zhisheng Z; Yayun Q; Feng J; Min Z; Haibo W; Youyang S; Hisamitsu T; Shintaro I; Shiyu G; Yanqing L
    Oncotarget; 2017 Jan; 8(2):2501-2513. PubMed ID: 27705934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteopontin promotes the malignant phenotypes of human hepatocellular carcinoma cell line SMMC-7721].
    Chen RX; Xue TC; Ye SL; Sun RX; Zhao Y; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jan; 15(1):37-40. PubMed ID: 17244457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell lines.
    Chae S; Jun HO; Lee EG; Yang SJ; Lee DC; Jung JK; Park KC; Yeom YI; Kim KW
    Int J Oncol; 2009 Dec; 35(6):1409-16. PubMed ID: 19885563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three-dimensional cell culture and histology of vasculogenic mimicry in hepatocellular carcinoma].
    Zhao J; Huang JS; Yang AJ; Wang CY; Liu W; Li M
    Ai Zheng; 2007 Feb; 26(2):123-6. PubMed ID: 17298738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The elevated expression of osteopontin and NF-κB in human aortic aneurysms and its implication.
    Mi T; Nie B; Zhang C; Zhou H
    J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):602. PubMed ID: 22038347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.
    Sun BS; Dong QZ; Ye QH; Sun HJ; Jia HL; Zhu XQ; Liu DY; Chen J; Xue Q; Zhou HJ; Ren N; Qin LX
    Hepatology; 2008 Dec; 48(6):1834-42. PubMed ID: 18972404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
    Rangaswami H; Bulbule A; Kundu GC
    Glycoconj J; 2006 May; 23(3-4):221-32. PubMed ID: 16691505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma.
    Takafuji V; Forgues M; Unsworth E; Goldsmith P; Wang XW
    Oncogene; 2007 Sep; 26(44):6361-71. PubMed ID: 17452979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROCK is involved in vasculogenic mimicry formation in hepatocellular carcinoma cell line.
    Zhang JG; Li XY; Wang YZ; Zhang QD; Gu SY; Wu X; Zhu GH; Li Q; Liu GL
    PLoS One; 2014; 9(9):e107661. PubMed ID: 25238232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.
    Cheng R; Cai XR; Ke K; Chen YL
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):719-725. PubMed ID: 29058285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
    Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
    J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
    Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
    Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
    IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
    Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
    Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.